Radiation biology in the context of changing patterns of radiotherapy

Radiation Research

Volumn 182, Issue 3, 2014, Pages 259-272

  Murray, David ^a   McBride, William H ^b   Schwartz, Jeffrey L ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

APOPTOSIS; AUTOPHAGY; BYSTANDER EFFECT; CANCER CELL; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CELL DEATH; CELL KILLING; CELL STRESS; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; HUMAN; IONIZING RADIATION; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; MITOTIC CATASTROPHE; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIOBIOLOGY; REVIEW; SENESCENCE; STRESS INDUCED PREMATURE SENESCENCE; TISSUE REPAIR; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; DNA DAMAGE; DOSE FRACTIONATION; HUMANS; NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84907302136     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13740.1     Document Type: Review

References (85)

1. Withers HR. The four R's of radiotherapy. In: Lett JT, Adler H, editors. Advances in Radiation Biology, vol. 5 New York: Academic Press; 1975. p. 241-71.
2. Thames H, Hendry J. Fractionation in radiotherapy. London: Taylor & Francis; 1987.
3. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering Committee. Radiother Oncol 1999; 52:137-48.
4. Fowler JF, Toma-Dasu I, Dasu A. Is the a/b ratio for prostate tumours really low and does it vary with the level of risk at diagnosis?. Anticancer Res 2013; 33:1009-11.
5. Dearnaley D, Syndikus I, Sumo G, Bidmead M, Bloomfield D, Clark C, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol 2012; 13:43-54.
6. Brown JM, Brenner DJ, Carlson DJ. Dose escalation, not "new biology", can account for the efficacy of stereotactic body radiotherapy (SBRT) with non-small cell lung cancer (NSCLC) [editorial]. Int J Radiat Oncol Biol Phys 2013; 85:1159-60.
7. Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry 1983; 46:797-803.
8. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303:1070-6.
9. Stephans K. Stereotactic body radiotherapy for stage I non-small cell lung cancer. Cleve Clin J Med 2012; 79:e-Suppl 1 e-S26-e- S31.
10. Finkelstein SE, Timmerman R, McBride WH, Schaue D, Hoffe SE, Mantz CA, et al. The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol 2011; 2011:439752.
11. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70:847-52.
12. Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M, et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82:1744-8.
13. Goodarzi AA, Jeggo PA. The repair and signaling responses to DNA double-strand breaks. Adv Genet 2013; 82:1-45.
14. Mirzayans R, Pollock S, Scott A, Enns L, Andrais B, Murray D. Relationship between the radiosensitizing effect of wortmannin, DNA double-strand break rejoining, and p21WAF1 induction in human normal and tumor-derived cells. Mol Carcinogenesis 2004; 39:164-72.
15. Sun Y, Nelson PS. Molecular pathways: Involving microenvironment damage responses in cancer therapy resistance. Clin Cancer Res 2012; 18:4019-25.
16. Schaue D, McBride WH. T lymphocytes and normal tissue responses to radiation. Front Oncol 2012; 2:119.
17. Schaue D, Xie MW, Ratikan JA, McBride WH. Regulatory T cells in radiotherapeutic responses. Front Oncol 2012; 2:90.
18. Vangestel C, Van de Wiele C, Mees G, Peeters M. Forcing cancer cells to commit suicide. Cancer Biother Radiopharm 2009; 24:395-407.
19. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4:139-63.
20. Kolesnick R, Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene 2003; 22:5897-906.
21. Corre I, Niaudet C, Paris F. Plasma membrane signaling induced by ionizing radiation. Mutat Res 2010; 704:61-7.
22. Syljuasen RG, McBride WH. Radiation-induced apoptosis and cell cycle progression in Jurkat T cells. Radiat Res 1999; 152:328-31.
23. Li Y, Zhang J, Chen X, Liu T, He W, Chen Y, Zeng X. Molecular machinery of autophagy and its implication in cancer. Am J Med Sci 2012; 343:155-61.
24. Golden EB, Pellicciotta I, Demaria S, Barcellos-Hoff MH, Formenti SC. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2012; 2:88.
25. Ratikan JA, Sayre JW, Schaue D. Chloroquine engages the immune system to eradicate irradiated breast tumors in mice. Int J Radiat Oncol Biol Phys 2013; 87:761-8.
26. Ianzini F, Bertoldo A, Kosmacek EA, Phillips SL, Mackey MA. Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells. Cancer Cell Int. 2006; 6:11.
27. Luce A, Courtin A, Levalois C, Altmeyer-Morel S, Romeo PH, Chevillard S, et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis 2009; 30:432-9.
28. Vakifahmetoglu H, Olsson M, Tamm C, Heidari N, Orrenius S, Zhivotovsky B. DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ 2008; 15:555-66.
29. Puck TT, Marcus PI. Action of x-rays on mammalian cells. J Exp Med 1956; 103:653-66.
30. Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 2007; 32:37-43.
31. Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, et al. Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery 2011; 150:1032-9.
32. Wu W, Liu P, Li J. Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol 2012; 82:249-58.
33. Rainaldi G, Ferrante A, Indovina PL, Santini MT. Induction of apoptosis or necrosis by ionizing radiation is dose-dependent in MG-63 osteosarcoma multicellular spheroids. Anticancer Res 2003; 23:2505-18.
34. Mirzayans R, Scott A, Cameron M, Murray D. Induction of accelerated senescence by c radiation in human solid tumorderived cell lines expressing wild-type TP53. Radiat Res 2005; 163:53-62.
35. Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 2005; 174:7516-23.
36. Suzuki M, Boothman DA. Stress-induced premature senescence (SIPS)-influence of SIPS on radiotherapy. J Radiat Res (Tokyo) 2008; 49:105-12.
37. Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 2008; 76:947-57.
38. Supiot S, Shubbar S, Fleshner N, Warde P, Hersey K, Wallace K, et al. A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies. Radiother Oncol 2008; 88:53-60.
39. Skinner HD, Sandulache VC, Ow TJ, Meyn RE, Yordy JS, Beadle BM, et al. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res 2012; 18:290-300.
40. Wu PC, Wang Q, Grobman L, Chu E, Wu DY. Accelerated cellular senescence in solid tumor therapy. Exp Oncol 2012; 34:298-305.
41. Jones KR, Elmore LW, Jackson-Cook C, Demasters G, Povirk LF, Holt SE, et al. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells. Int J Radiat Biol 2005; 81:445-58.
42. DeMasters GA, Gupta MS, Jones KR, Cabot M, Wang H, Gennings C, et al. Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089. J Steroid Biochem Mol Biol 2004; 92:365-74.
43. Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells 2012; 30:833-44.
44. Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A, et al. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Ageing Dev 2009; 130:24-32.
45. Rajaraman R, Rajaraman MM, Rajaraman SR, Guernsey DL. Neosis - a paradigm of self-renewal in cancer. Cell Biol Int 2005; 29:1084-97.
46. Gewirtz DS. Autophagy, senescence and tumor dormancy in cancer therapy. Autophagy 2009; 5:1232-4.
47. Elmore LW, Di X, Dumur C, Holt SE, Gewirtz DA. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Clin Cancer Res 2005; 11:2637-43.
48. Wang Q, Wu PC, Dong DZ, Ivanova I, Chu E, Zeliadt S, et al. Polyploidy road to therapy-induced cellular senescence and escape. Int J Cancer 2013; 132:1505-15.
49. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5:99-118.
50. Ungvari Z, Podlutsky A, Sosnowska D, Tucsek Z, Toth P, Deak F, et al. Ionizing radiation promotes the acquisition of a senescenceassociated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity. J Gerontol A Biol Sci Med Sci 2013; 68:1443-57.
51. Basu D, Reyes-Mugica M, Rebbaa A. Role of the beta catenin destruction complex in mediating chemotherapy-induced senescence- associated secretory phenotype. PLoS One 2012; 7(12): e52188.
52. Laberge RM, Awad P, Campisi J, Desprez PY. Epithelialmesenchymal transition induced by senescent fibroblasts. Cancer Microenviron 2012; 5:39-44.
53. Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, et al. SASP mediates chemoresistance and tumorinitiating- activity of mesothelioma cells. Oncogene 2012; 31:3148-63.
54. Tsai KKC, Stuart J, Chuang YYE, Little JB, Yuan ZM. Low-dose radiation-induced senescent stromal fibroblasts render nearby breast cancer cells radioresistant. Radiat Res 2009; 172:306-13.
55. Chen FH, Chiang CS, Wang CC, Tsai CS, Jung SM, Lee CC, et al. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res 2009; 15:1721-9.
56. Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 2010; 107:8363-8.
57. Wang SC, Yu CF, Hong JH, Tsai CS, Chiang CS. Radiation therapy-induced tumor invasiveness is associated with SDF-1- regulated macrophage mobilization and vasculogenesis. PLoS One 2013; 8(8):e69182.
58. Sidi R, Pasello G, Opitz I, Soltermann A, Tutic M, Rehrauer H, et al. Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysis. Eur J Cancer 2011; 47:326-32.
59. Mancuso M, Pasquali E, Giardullo P, Leonardi S, Tanori M, Di Majo V, et al. The radiation bystander effect and its potential implications for human health. Curr Mol Med 2012; 12:613-24.
60. Hei TK, Zhou H, Chai Y, Ponnaiya B, Ivanov VN. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol 2011; 4:96-105.
61. Hamada N, Maeda M, Otsuka K, Tomita M. Signaling pathways underpinning the manifestations of ionizing radiation-induced bystander effects. Curr Mol Pharmacol 2011; 4:79-95.
62. Tasdemir N, Lowe SW. Senescent cells spread the word: non-cell autonomous propagation of cellular senescence. EMBO J 2013; 32:1975-6.
63. Kishikawa H, Wang K, Adelstein SJ, Kassis AI. Inhibitory and stimulatory bystander effects are differentially induced by Iodine- 125 and Iodine-123. Radiat Res 2006; 165:688-94.
64. McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, et al. A sense of danger from radiation. Radiat Res 2004; 162:1-19.
65. Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009; 15:5379-88.
66. Levy A, Chargari C, Cheminant M, Simon N, Bourgier C, Deutsch E. Radiation therapy and immunotherapy: implications for a combined cancer treatment. Crit Rev Oncol Hematol 2013; 85:278-87.
67. Ludgate CM. Optimizing cancer treatments to induce an acute immune response: radiation Abscopal effects, PAMPs, and DAMPs. Clin Cancer Res 2012; 18:4522-5.
68. Stone HB, Peters LJ, Milas L. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst 1979; 63:1229-35.
69. Liao YP, Wang CC, Schaue D, Iwamoto KS, McBride WH. Local irradiation of murine melanoma affects the development of tumour-specific immunity. Immunol 2009; 128(1 Suppl): e797-804.
70. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009; 114:589-95.
71. Demaria S, Formenti SC. Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol 2012; 2:153.
72. Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 2012; 83:1306-10.
73. Pajonk F, McBride WH. Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. Radiother Oncol 2001; 59:203-12.
74. Hong JH, Chiang CS, Campbell IL, Sun JR, Withers HR, McBride WH. Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 1995; 33:619-26.
75. Roses RE, Xu M, Koski GK, Czerniecki BJ. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer. Oncogene 2008; 27:200-7.
76. Schaue D, Comin-Anduix B, Ribas A, Zhang L, Goodglick L, Sayre JW, et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res 2008; 14:4883-90.
77. Slovin SF, Higano CS, Hamid O, Tejwani S, Harzstark A, Alumkal JJ, et al. Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study. Ann Oncol 2013; 24:1813-21.
78. Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. New Engl J Med 2012; 366:925-31.
79. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300(5622): 1155-9.
80. Kolesnick R, Fuks Z. Response to comments on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (II). Science 2003; 302(5652):1894e.
81. García-Barros M, Thin TH, Maj J, Cordon-Cardo C, Haimovitz- Friedman A, Fuks Z, et al. Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res 2010; 70:8179-86.
82. Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004; 5:429-41.
83. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005; 8:89-91.
84. Brown JM, Koong AC. High-dose single-fraction radiotherapy: exploiting a new biology?. Int J Radiat Oncol Biol Phys 2008; 71:324-5.
85. Verhaegen F, Granton P, Tryggestad E. Small animal radiotherapy research platforms. Phys Med Biol 2011; 56:R55-83.